Objective: Decreased T-cell reactivity in vitro is strongly associated
with progression to AIDS and low CD4+ T-cell numbers. Low T-cell resp
onses in vitro induced by CD3 monoclonal antibody (mAb) are predictive
for progression to AIDS independent of low CD4+ T-cell counts and hig
h HIV-1 RNA levels. We developed a whole-blood lymphocyte culture syst
em in which T cells were stimulated by a combination of CD3 and CD28 m
AB. Combined stimulation of CD28, a costimulatory molecule, and CD3 co
nsiderably enhances T-cell responses in vitro and reduces variation co
efficients, which may increase the prognostic power of T-cell response
s. Design: A prospective study of HIV-l-infected homosexual men follow
ed for 35 months. Methods: The predictive value of low T-cell response
s to CD3 plus CD28 mAb relative to low CD4+ T-cell counts, high HIV-1
RNA levels and the presence of syncytium-inducing (SI) HIV-1 variants
was evaluated longitudinally in 202 HIV-1-infected homosexual men foll
owed for 35 months. Results: In multivariate analysis, decreased T-cel
l responses at baseline were predictive of development of AIDS, indepe
ndent of law CD4+ T-cell numbers and high HIV-1 RNA levels. In a time-
dependent model, HIV-1 RNA levels lost their predictive value, whereas
low T-cell responses, low CD4+ T-cell numbers and the presence of SI
HIV-1 variants independently predicted AIDS. Conclusions: These data d
emonstrate that combined use of virological and immunological markers
may be useful in monitoring disease progression and response to antire
troviral therapy. (C) 1998 Lippincott Williams & Wilkins.